Skip to content

The silent inactivation phenomenon in E. coli asparaginase therapy

Release Date: 26 Jun 2025 MDLinx
College of American Pathologists Logo

CAP Member Adam Cloe, MD, FCAP, explains the silent inactivation of E. coli asparaginase. “In silent inactivation, the anti-asparaginase antibodies don't cause an allergic reaction but do neutralize the asparaginase, so it no longer works,” said Dr. Cloe.

For the full article click here: The silent inactivation phenomenon in E. coli asparaginase therapy

adding all to cart
False 0
File added to media cart.